《幽门螺杆菌感染的处理:Maastricht Ⅴ/Florence共识报告》解读

被引:48
作者
刘文忠
机构
[1] 上海交通大学医学院附属仁济医院消化内科上海市消化疾病研究所
关键词
幽门螺杆菌; Maastricht Ⅴ共识报告; 诊断; 治疗; 消化不良; 胃肿瘤; 预防医学; 胃微生物群;
D O I
暂无
中图分类号
R573 [胃疾病];
学科分类号
100201 [内科学];
摘要
2015年10月8—9日,"幽门螺杆菌感染的处理:Maastricht V共识会议"在意大利佛罗伦萨举行。会议达成了下列幽门螺杆菌感染处理方面的新共识:1指征/相关性;2诊断;3治疗;4预防/公共卫生;5幽门螺杆菌和胃微生物群。本文对这些内容进行详细解读。
引用
收藏
页码:577 / 584
页数:8
相关论文
共 20 条
[1]
Primary antibiotic resistance of Helicobacter pylori strains isolated from patients with dyspeptic symptoms in Beijing: A prospective serial study [J].
Zhang, Yue-Xi ;
Zhou, Li-Ya ;
Song, Zhi-Qiang ;
Zhang, Jian-Zhong ;
He, Li-Hua ;
Ding, Yu .
WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (09) :2786-2792
[2]
第四次全国幽门螺杆菌感染处理共识报告 [J].
刘文忠 ;
谢勇 ;
成虹 ;
吕农华 ;
胡伏莲 ;
张万岱 ;
周丽雅 ;
陈烨 ;
曾志荣 ;
王崇文 ;
萧树东 ;
潘国宗 ;
胡品津 .
胃肠病学, 2012, 17 (10) :618-625
[3]
Adverse events with bismuth salts for Helicobacter pylori eradication: Systematic review and meta-analysis [J].
Ford, Alexander C. ;
Malfertheiner, Peter ;
Giguere, Monique ;
Santana, Jose ;
Khan, Mostafizur ;
Moayyedi, Paul .
WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (48) :7361-7370
[4]
重视根除幽门螺杆菌在消化不良处理中的应用.[J]..中华内科杂志.2008, 01
[5]
努力提高幽门螺杆菌的根除率 [J].
刘文忠 ;
萧树东 .
中华内科杂志, 2009, (08)
[6]
Helicobacter pylori therapy: a paradigm shift [J].
Graham, David Y. ;
Dore, Maria Pina .
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2016, 14 (06) :577-585
[7]
Tailored versus Triple plus Bismuth or Concomitant Therapy as Initial Helicobacter pylori Treatment: A Randomized Trial [J].
Zhou, Liya ;
Zhang, Jianzhong ;
Song, Zhiqiang ;
He, Lihua ;
Li, Yanqing ;
Qian, Jiaming ;
Bai, Peng ;
Xue, Yan ;
Wang, Ye ;
Lin, Sanren .
HELICOBACTER, 2016, 21 (02) :91-99
[8]
Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: a Systematic Review and Meta-analysis.[J].Yi-Chia Lee;Tsung-Hsien Chiang;Chu-Kuang Chou;Yu-Kang Tu;Wei-Chih Liao;Ming-Shiang Wu;David Y. Graham.Gastroenterology.2016,
[9]
A large randomised controlled intervention trial to prevent gastric cancer by eradication of Helicobacter pylori in Linqu County, China: baseline results and factors affecting the eradication [J].
Pan, Kai-feng ;
Zhang, Lian ;
Gerhard, Markus ;
Ma, Jun-ling ;
Liu, Wei-dong ;
Ulm, Kurt ;
Wang, Jian-xi ;
Zhang, Lei ;
Zhang, Yang ;
Bajbouj, Monther ;
Zhang, Lan-fu ;
Li, Ming ;
Vieth, Michael ;
Liu, Rui-yong ;
Quante, Michael ;
Wang, Le-hua ;
Suchanek, Stepan ;
Zhou, Tong ;
Guan, Wei-xiang ;
Schmid, Roland ;
Classen, Meinhard ;
You, Wei-cheng .
GUT, 2016, 65 (01) :9-18
[10]
Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments [J].
Gisbert, J. P. ;
Romano, M. ;
Gravina, A. G. ;
Solis-Munoz, P. ;
Bermejo, F. ;
Molina-Infante, J. ;
Castro-Fernandez, M. ;
Ortuno, J. ;
Lucendo, A. J. ;
Herranz, M. ;
Modolell, I. ;
del Castillo, F. ;
Gomez, J. ;
Barrio, J. ;
Velayos, B. ;
Gomez, B. ;
Dominguez, J. L. ;
Miranda, A. ;
Martorano, M. ;
Algaba, A. ;
Pabon, M. ;
Angueira, T. ;
Fernandez-Salazar, L. ;
Federico, A. ;
Marin, A. C. ;
McNicholl, A. G. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (08) :768-775